Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyohei Abe

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Surgical Oncology|December 18, 2024
Timing of TS1 adjuvant chemotherapy as a prognostic factor in recurrent pancreatic cancer after surgeryKyohei Abe, Kenei Furukawa, Mizuki Fukuda, et al.
Clinical Journal of Gastroenterology|April 16, 2026
​Extensive high-grade PanIN of the main pancreatic duct requiring total pancreatectomy diagnosed after long-term surveillanceRyo Yaguchi, Ryoga Hamura, Nanako Kodaira, et al.
International Journal of Clinical Oncology|March 30, 2025
Simple definition of biologically borderline resectable colorectal liver metastases based on early surgical failureKenei Furukawa, Masashi Tsunematsu, Koichiro Haruki, et al.
The American Surgeon|September 30, 2023
The Impact of Fibrinogen to Prognostic Nutritional Index Rate on Prognosis of Pancreatic Ductal AdenocarcinomaYosuke Igarashi, Yoshihiro Shirai, Yoshiaki Tanji, et al.
Transplantation Proceedings|April 26, 2023
Liver Only Living Donor Transplantation for Polycystic Disease in a Patient on Chronic Hemodialysis: Case ReportMitsuru Yanagaki, Koichiro Haruki, Kenei Furukawa, et al.
Anticancer Research|March 27, 2024
Effect of Risk Factor Score on Early Recurrence After Pancreatectomy for Invasive Pancreatic Ductal AdenocarcinomaMichinori Matsumoto, Yoshihiro Shirai, Kyohei Abe, et al.
Anticancer Research|March 28, 2023
A Multidisciplinary Treatment Strategy With Conversion Surgery for Hepatocellular CarcinomaHironori Shiozaki, Kenei Furukawa, Koichiro Haruki, et al.
Surgery Today|June 30, 2025
The preoperative cachexia index predicts outcomes after pancreatic resection for resectable pancreatic cancerRyoga Hamura, Yoshihiro Shirai, Masashi Tsunematsu, et al.
Anticancer Research|December 30, 2022
D1 Distal Pancreatectomy for Left-sided Pancreatic Ductal Adenocarcinoma Is Justifiable: A Propensity-score Matched Multicenter StudyTaro Sakamoto, Takeshi Gocho, Masashi Tsunematsu, et al.
Surgical Oncology|September 28, 2023
Superior mesenteric vein/portal vein contact in preoperative imaging indicates biological malignancy in anatomically resectable pancreatic cancerYoshihiro Shirai, Shinji Onda, Yoshiaki Tanji, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Surgical Oncology|December 18, 2024
Timing of TS1 adjuvant chemotherapy as a prognostic factor in recurrent pancreatic cancer after surgeryKyohei Abe, Kenei Furukawa, Mizuki Fukuda, et al.
Clinical Journal of Gastroenterology|April 16, 2026
​Extensive high-grade PanIN of the main pancreatic duct requiring total pancreatectomy diagnosed after long-term surveillanceRyo Yaguchi, Ryoga Hamura, Nanako Kodaira, et al.
International Journal of Clinical Oncology|March 30, 2025
Simple definition of biologically borderline resectable colorectal liver metastases based on early surgical failureKenei Furukawa, Masashi Tsunematsu, Koichiro Haruki, et al.
The American Surgeon|September 30, 2023
The Impact of Fibrinogen to Prognostic Nutritional Index Rate on Prognosis of Pancreatic Ductal AdenocarcinomaYosuke Igarashi, Yoshihiro Shirai, Yoshiaki Tanji, et al.
Transplantation Proceedings|April 26, 2023
Liver Only Living Donor Transplantation for Polycystic Disease in a Patient on Chronic Hemodialysis: Case ReportMitsuru Yanagaki, Koichiro Haruki, Kenei Furukawa, et al.
Anticancer Research|March 27, 2024
Effect of Risk Factor Score on Early Recurrence After Pancreatectomy for Invasive Pancreatic Ductal AdenocarcinomaMichinori Matsumoto, Yoshihiro Shirai, Kyohei Abe, et al.
Anticancer Research|March 28, 2023
A Multidisciplinary Treatment Strategy With Conversion Surgery for Hepatocellular CarcinomaHironori Shiozaki, Kenei Furukawa, Koichiro Haruki, et al.
Surgery Today|June 30, 2025
The preoperative cachexia index predicts outcomes after pancreatic resection for resectable pancreatic cancerRyoga Hamura, Yoshihiro Shirai, Masashi Tsunematsu, et al.
Anticancer Research|December 30, 2022
D1 Distal Pancreatectomy for Left-sided Pancreatic Ductal Adenocarcinoma Is Justifiable: A Propensity-score Matched Multicenter StudyTaro Sakamoto, Takeshi Gocho, Masashi Tsunematsu, et al.
Surgical Oncology|September 28, 2023
Superior mesenteric vein/portal vein contact in preoperative imaging indicates biological malignancy in anatomically resectable pancreatic cancerYoshihiro Shirai, Shinji Onda, Yoshiaki Tanji, et al.
Pageof 3